Rating History for Halozyme Therapeutics (HALO) by Roth Capital

More Stocks Rated by Roth Capital | Latest Ratings for HALO
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
8/11/2011 New Coverage Buy
(N/A)		 14.00
(N/A)		 6.02 7.96 32.23% Details
3/24/2011 Upgrade Buy
(N/A)		 N/A
(N/A)		 6.43 6.02 -6.38% Details